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The effect of thymidine kinase (TK) encoded by herpes simplex virus type 1(HSV-1) strain KOS in DNA replication fidelity
was examined by two different mutagenesis assays. Mutagenesis assay of the LacZ reporter gene present in recombinant
tkLTRZ1, which contained the integrated LacZ gene in the tk locus, revealed a less than 0.05% mutation frequency of the LacZ
gene regardless of whether the viruses were propagated in TK-expressing cells or control cells, conflicting an earlier report
that a HSV-1 TK strain replicated a 0.5% mutation frequency of the LacZ gene (R. B. Pyles and R. L. Thompson, 1994, J. Virol.
68, 4514–4524). Furthermore, TK-proficient and -deficient recombinant viruses replicated with similar mutation frequencies
(0.027 and 0.026%, respectively) of the LacZ gene, which was integrated in the polymerase locus. Results of SupF
mutagenesis assay demonstrated that neither the spectra of mutation nor the mutation frequencies of SupF gene, which was
integrated in the tk locus of recombinant, were significantly different (P  0.05) in progeny viruses grown in TK-expressingdid not have detectable mutator activity. © 2003 Elsevier Scie
INTRODUCTION
The herpes simplex virus type 1 (HSV-1)-encoded thy-
midine kinase (TK) is not essential for viral replication in
certain tissues. However, it plays a critical role in acute
viral replication or reactivation of virus from latent gan-
glia in animal models (Tensor and Edris, 1987; Jacobson
et al., 1993; Efstathiou et al., 1989; Coen et al., 1989a,b).
This could be related to its biological property of being
able to process multiple kinase activities: phosphorylate
deoxythymidine (dT), deoxyuridine (dU), deoxycytidine
(dC), and thymidylate (dTMP) (Chen and Prusoff, 1978;
Chen et al., 1979a,b; Jamieson et al., 1974b; Jamieson and
Subak-Sharpe, 1974). In normal human cells phosphory-
lation of these substrates are performed by human TK
(hTK), deoxycytidine kinase (hdCK), and TMP kinase (hT-
MPK). Therefore, it is reasonable that the TK-defective
HSV-1 mutant replicates efficiently in cells expressing
such kinase activities, but not in cells lacking such ac-
tivities, especially in terminally differentiated neuronal
cells. Furthermore, TK serves as an antiviral target; it is
able to phosphorylate certain antiviral drugs, such as
acyclovir and bromovinyldeoxyuridine, and the loss of TK
activity confers resistance to these antiviral drugs.
In addition to these biological properties, Pyles and
Thompson (1994) demonstrated that TK has mutator ac-
tivity in replicating an integrated LacZ gene (Pyles and
Thompson, 1994). Our recent work, however, conflicts
with this article. We showed that TK and TK HSV-1© 2003 Elsevier Science (USA)
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strains exhibited similar SupF mutation frequencies in a
transient DNA replication assay (Hwang et al., 2002).
Since the SupF gene used in this mutagenesis assay is
induced to replicate as extrachromosomal DNA that
might account for the observed differences between
these two studies.
In this article, recombinants derived from HSV-1 strain
KOS with the LacZ or SupF integrated in the viral genome
were propagated in derivatives of Vero cells, that either
expressed viral TK (TK) or not (TK), then subjected for
the fidelity analyses. Results demonstrated that progeny
viruses propagated in TK cells did not exhibit an in-
crease in mutation frequency in the LacZ or SupF genes
compared to the progeny viruses obtained from TK
cells. Furthermore, TK and TK recombinants did not
exhibit different LacZ mutation frequencies. Therefore,
the HSV-1 TK has no mutator activity in our assay sys-
tems.
RESULTS
Our previous study of HSV-1 DNA replication fidelity
demonstrated that a virus with or without TK did not
exhibit different mutation frequencies of SupF gene
when the SupF genes were replicated as episomal DNAs
(Hwang et al., 2002). This result conflicts with a previous
finding that HSV-1 TK had mutator activity for the LacZ
gene when it was integrated in viral genomic DNA
(Phyles and Thompson, 1994). However, the differences
might be attributed to the difference of forms and con-
texts of target genes being replicated. To examinecells and control cells. Therefore, both LacZ and SupF mu
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0042-6822/03 $30.00sis assays demonstrated that TK of the HSV-1 strain KOS
whether these factors could lead to the observed differ-
ences, we constructed cell lines, which are capable oftagene
nce (USA
expression HSV-1 TK, for propagating viruses and exam-
ining the DNA replication fidelity of both SupF and LacZ
genes in the context of viral genome.
TK-expressing cell lines
Since the recombinant viruses used in this study are
TK due to the insertion of LacZ or SupF within the tk
locus, V658A and V658B cell lines were constructed to
contain integrated tk gene(s). The V658C cell line, that
was resistant to G418 but did not contain the integrated
tk gene, and the parental Vero cells served as the con-
trol. Southern blots (Fig. 1) demonstrated the presence of
integrated tk gene(s) in both V658A and V658B cells but
not in V658C cells. The 410-bp probe, corresponding to
sequences upstream of the tk locus, hybridized to two
and three BamHI fragments of V658A and V658B DNA,
respectively (Fig. 1B). The PstI 850-bp probe, that con-
tains sequences corresponding to the amino-terminal
two-third of the tk gene, hybridized to one and four
BamHI fragments of V658A and V658B DNA, respectively
(Fig. 1C). The 303-bp probe (Fig. 1D), that contains se-
quences corresponding the C-terminus of the tk gene,
hybridized to one and four bands of V658B and V658B
DNA, respectively. Higher molecular weight bands
shown in Figs. 1C and 1D could be due to incomplete
digestion of V658B DNA. Different mobility of the hybrid-
ized bands of V658A DNA shown in Fig. 1 could be the
results of artifacts of gel preparation. Nevertheless,
these results demonstrated that V658A and V658B cells
contained one and three copies (indicated by asterisks)
of the full-length tk gene, respectively.
We next examined whether these cells were capable
of expressing HSV-1 TK by Western blot analysis. Figure
2 demonstrated that KOS/F-B failed to induce TK expres-
sion in V658C cells that lack the integrated tk gene,
whereas infection of both V658A and V658B with this
virus induced HSV-1 TK expression. For quantification,
one-third volume of KOS-infected V658C cell lysate, rel-
ative to V658A and V658B cell lysates, was loaded onto
the SDS–PAGE. Interestingly, V658A, but not V658B, ex-
FIG. 1. (A) Map of the 3.6-kb BamHI fragment of HSV-1 strain KOS DNA. Relative positions of BamHI (B) and PstI (P) restriction sites are shown.
The box above the line depicts the TK open reading frame with the arrow indicating the orientation. Relative positions of three probes used in Southern
blots are shown below the line. (B), (C), and (D) Southern blots. Results of Southern blots using 410-, 850-, and 303-bp probes, respectively. Lane 1:
10–25 pg of BamHI-digested pHC658 DNA; Lanes 2, 3, 4, and 5: 10 g each of genomic DNA isolated from Vero, V658A, V658B, and V658C,
respectively. *, DNA fragment containing the full-length tk gene. Lambda DNA digested with BstEII with the molecular sizes (in kilobase pairs) is
shown at the left.
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pressed TK without virus infection, although the level of
TK detected in uninfected cells was lower. Quantitatively,
the amount of TK expressed in V658A in the absence of
virus infection (Fig. 2; Lane 4) was 12% of that expressed
in wild-type strain KOS-infected V658C cells (Fig. 2; Lane
2). Upon infection of V658A and V658B cells with strain
KOS/F-B, TK expressions were induced by 27% (Lane 5)
and 17% (Lane 7), respectively, relative to that of KOS-
infected V658C cells (Lane 2). Similar results were ob-
tained when the TK-negative strain dlsactk was used to
infect these cells (data not shown). Therefore, both
V658A and V658B were able to express HSV-1 TK after
HSV-1 infection.
To determine whether TK expressed in V658A and
V658B cells was functionally active, a plaque reduction
assay was performed using GCV. If TK expressed in
V658A and V658B was active, then GCV would inhibit the
growth of TK HSV-1 on those cells. Table 1 showed that
in the presence of 5 M GCV, wild-type strain KOS failed
to form any plaque on these cell lines. While TK-negative
recombinants, KOS/F-B and dlsactk, were able to repli-
cate and form plaques on V658C cells, the addition of 5
M GCV to V658A and V658B cells resulted in the inhi-
bition of plaque formation induced by both viruses.
These results demonstrated that TK expressed in V658A
and V658B cells was active.
Another indication of TK activity in these cells is the
utilization of [3H]thymidine as a substrate. When TK is
active, viruses will incorporate the metabolized [3H]thy-
midine to form radiolabeled plaques that can be visual-
ized by autoradiography. Plaque autoradiography was
performed to demonstrate the ability of TK expressed in
V658B cells to phosphorylate [3H]thymidine and incorpo-
rate the radiolabel into viral plaques. Figure 3 showed
that KOS formed radiolabeled plaques on both V658B
and V658C cells. While the KOS/F-B recombinant virus
failed to form radiolabeled plaques on infected V658C
cells, this recombinant did form radiolabeled plaques on
V658B cells. Quantitatively, the amount of radiolabeled
thymidine incorporated by KOS and KOS/F-B on V658B
cells was 93 and 70%, respectively, relative to that incor-
porated in KOS plaques formed on V658C cells. Further-
more, the plaque size of KOS/F-B formed on V658C cells
was smaller relative to that of KOS plaques (Fig. 3). On
the other hand, both KOS and KOS/F-B formed similar
size of plaques on V658B cells that was larger than KOS
plaques formed on V658C cells. Similar results were
observed for dlsactk infection on these cells (data not
shown). These results demonstrated that TK expressed
in V658A and V658B cells was functionally active, de-
spite the lower level of TK expression in these cells
relative to that in KOS-infected cells.
-Galactosidase mutagenesis assays
To examine whether TK expressed in V658A and
V658B had mutator activity, we performed a mutagenesis
FIG. 2. Expression of TK polypeptides. V658A, V658B, and V658C
cells were mock-infected or infected with KOS or KOS/F-B viruses
(m.o.i. of 3) for 7 h. Cell lysates were subjected to Western blot analysis
as described under Materials and Methods. Lane 2 was loaded with
approximately one-third the volume loaded in other lanes. The relative
intensity of each band was quantified as described. The amount of TK
expressed in KOS-infected V658C cells was defined as 100% and
applied to normalize the relative amount of TK expressed in other
samples.
TABLE 1
Effects of GCV in Plaque Formation in TK Cells
Virus
V658A V658B V658C
No drug GCV* No drug GCV No drug GCV
KOS 341 0 325 0 332 0
KOS/F-B 131 0 132 0 127 145
dlSactk 462 0 428 0 461 435
* 5 M of GCV was used to examine the ability of cells in inhibiting the plaque formation.
 Number of plaques formed at 72 h after virus inoculation.
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assay using the loss of -galactosidase activity as the
indicator of the LacZ mutation. The sensitivity of this
approach was first tested by measuring the ratio of clear
plaques (-gal) to the background of blue plaques (-
gal). This was performed by mixing KOS and tkLTRZ1
viruses at different ratios, inoculating them onto Vero
cells at a density of equal to or less than 150 plaques per
well of a six-well plate, then staining the plaques with
X-Gal. These experiments demonstrated that clear
plaques were identified on six-well plates when the input
ratio of KOS to tkLTRZ1 was as low as 0.22%. Therefore,
this method was sensitive enough to identify an individ-
ual clear plaque from the background of 500 blue
plaques when the virus was plated at a low density.
The first experiment examined the presence of LacZ
mutant in tkLTRZ1 progeny viruses amplified on V658C,
V658A, and V658B cells (Table 2). No real clear plaques
were isolated from these plaques examined. Although
several appeared to be clear plaques on the first exam-
ination, none remained clear upon subsequent replating
and staining. To reduce the possibility of mixed clear and
blue plaques, a second experiment was undertaken in
which aggregates of virus particles were filtered out prior
to analysis. Under these conditions viruses titers de-
creased about 50% and a few plaque-forming units (PFU)
were applied to six-well plates preseeded with Vero
cells. Again, no clear plaques were identified among
FIG. 3. Plaque autoradiography. V658B and V658C cells were inoculated with 100 to 200 PFU of either KOS or KOS/F-B, and plaque
autoradiography was performed as described under Materials and Methods. Numbers shown below each image are the relative plaque size and
radiolabeled activity of each sample. The plaque size of KOS-infected V658C cells was defined as 100% and relative plaque sizes of other samples
were determined. The radiolabeled intensity of plaques formed on KOS-infected V658C cells was defined as 100% after subtraction from the
background intensity, denoted as a dash, of KOS/F-B plaques on V658C cells.
TABLE 2
Mutation Frequencies of the Lac Z Gene
Virus Host cells
No. plaques mutant/
total plaques
Mutation
frequency (%)
Exp. I tkLTRZ1 V658A 0/5400 0.019
V658B 0/5400 0.019
V658C 0/2500 0.04
Exp. II tkLTRZ1 V658A 0/6531 0.015
V658B 0/8005 0.012
Vero 0/2142 0.047
Exp. III tkLTRZ1 V658A 1/6218 0.016
V658B 1/6730 0.015
V658C 0/4045 0.025
Exp. IV HP66 Pol A5 3/11201 0.027%
HPF-11 Pol A5 3/11510 0.026%
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2142, 6531, and 8005 plaques of progeny viruses ampli-
fied from Vero, V658A, and V658B cells, respectively. Of
note is that Vero cells were used in this experiment as a
control of TK cells and no LacZ mutant was identified
among progeny viruses amplified in these cells, similar
to that of V658C cells. Therefore, under our assay con-
ditions, the relative mutation frequencies of the LacZ
gene present in tkLTRZ1 were less than 0.05 and 0.02%
when the viruses were propagated in TK and TK cells,
respectively.
Since examination of the living plaques might have
missed certain clear plaques, a modified method of
Pyles and Thompson (1994) was also applied to examine
the LacZ mutants present in the progeny of tkLTRZ1
propagated on V658A, V658B, and V658C cells. When
infected cells were fixed and stained with X-Gal, one
mutant each was identified among tkLTRZ1 progeny vi-
ruses amplified on V658A (0.016%) and V658B (0.015%)
cells, and none among 4046 plaques amplified on V658C
(0.025%) cells (Table 2; Exp. III). These results clearly
differed from the 0.5% frequency of the LacZ mutations
observed in progeny viruses of TK HSV-1 recombinant
(Pyles and Thompson, 1994).
There was a concern that the impacts of TK expressed
in V568A and V658B cells on DNA replication fidelity
might not be similar to those in cells infected by TK
viruses. We, therefore, also examined the LacZ mutation
frequencies of TK (HP66) and TK (HPF-11) recombi-
nants. Results (Table 2; Exp. IV) demonstrated that both
recombinants exhibited similar LacZ mutation frequen-
cies (0.027 and 0.026%, respectively).
SupF mutagenesis assay
Recombinants KOS/F-A and -B were used to examine
the mutation frequencies of the SupF genes in the pres-
ence or absence of HSV-1 TK. Table 3 showed the results
of SupF mutation frequencies derived from progeny vi-
ruses propagated in these cells. In these experiments
the input viruses were limited to less than 200 PFU to
minimize inoculation of preexisting mutants. The SupF
gene in these recombinants exhibited at a mutation fre-
quency ranging from 0.011 to 0.028%, consistent with our
previous study (Hwang et al., 2002). These viruses rep-
licated with similar SupF mutation frequencies in TK
and TK cells, although the mutation frequencies varied
between experiments. Furthermore, these mutation fre-
quencies were consistent with those found in the LacZ
mutagenesis assays (Table 2).
Spectra of SupF mutations
To determine the spectra of SupF mutations, plasmid
DNA were prepared from mutant clones and analyzed.
The majority of mutants were point mutations (data not
shown); the distribution of base substitutions and mu-
tants with a single nucleotide deletion is shown in Fig. 4.
Although different substitutions were observed at sev-
eral nucleotide positions in the SupF gene, the overall
distributions of substitutions between these two groups
were not different. Table 4 summarizes the types of base
substitutions. Although the frequencies of transitions and
transversions between these two groups were slightly
different, which could be the results of isolating of mul-
tiple daughter mutants in the same experiment (Fig. 4),
they were not statistically significant (P  0.05) (Fisher
and van Belle, 1993). Therefore, neither the frequencies
nor the spectra of SupF mutations were significantly
different when the SupF genes were replicated in TK
and TK cells, demonstrating that HSV-1 TK expressed in
these cells did not have mutator activity in viral DNA
replication.
DISCUSSION
HSV-1 TK plays an important biological role in viral
pathogenesis involving reactivation from latency in neu-
ronal cells that are nondividing or terminally differenti-
ated. This has been demonstrated in animal models that
HSV-1 mutants deficient in TK activity are less efficiently
reactivated from latently infected ganglia (Tensor and
Edris, 1987; Jacobson et al., 1993; Efstathiou et al., 1989;
Coen et al., 1989a,b). However, HSV-1 TK is not required
for viral replication in cells that are actively dividing. In
examining the roles of TK activity in cell cultures, Pyles
and Thompson (1994) reported that HSV-1 TK had muta-
tor activity on viral DNA replication of the LacZ gene. Our
previous study (Hwang et al., 2002) demonstrated other-
wise. Wild-type strain KOS and its TK-deficient mutant
exhibited similar mutation frequency of the SupF target
gene. These conflicting results raised the important
question of whether HSV-1 TK has mutator activity. Since
there is a fundamental difference between the SupF
(Hwang et al., 2002) and LacZ mutagenesis assay (Pyles
and Thompson, 1994), we reevaluated the effects of TK in
DNA replication fidelity.
In this study cells containing integrated HSV-1 tk gene
TABLE 3
Mutation Frequencies of the SupF Gene
V658A V658B V658C
Exp. I.
KOS/F-A 8/38,095
(0.021%)a
44/177,900
(0.026%)
44/159,386
(0.028%)
KOS/F-B 44/166,574
(0.026%)
21/99,269
(0.021%)
NDb
Exp. II.
KOS/F-B 9/53,798
(0.016%)
13/115,794
(0.011%)
16/117,056
(0.014%)
a Number of mutant colonies/total number recovered (mutation fre-
quency).
b ND, not determined due to the loss of DNA sample.
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were constructed. Although these cells expressed less
than 30% of the normal amount of TK in KOS-infected
cells, the expressed TK was functionally active at the
cellular level. This was shown by its ability to activate
GCV and the ability to phosphorylate [3H]thymidine for
incorporation into viral plaques induced by TK-negative
viruses. Furthermore, the amount of TK expressed in
these cells would be sufficient for its biological roles in
reactivation from latency. Previous studies demonstrated
that 10% of viral TK activity was sufficient for viral
replication and reactivation from neuronal tissues (Coen
et al., 1989a,b; Irmiere et al., 1989). Similarly, HSV-1 re-
combinant expressing hTK equivalent to only 5% of
viral TK was sufficient for viral replication and reactiva-
tion in ganglionic tissues (Chen et al., 1998). Therefore,
cells expressing approximately 15 to 30% of wild-type
viral TK polypeptides would provide an environment
equivalent to that induced by TK-competent viruses dur-
ing lytic infection.
The recombinant virus tkLTRZ1 that is deficient in
HSV-1 TK (Davar et al., 1994) exhibited less than 0.02% of
the LacZ mutation frequency, when it was propagated in
TK cells. Furthermore, TK (HP66) and TK (HPF-11)
recombinants replicated similar LacZ mutation frequen-
cies. This was consistent with our previous study, which
showed that wild-type strain KOS and its TK-deficient
mutant did not induce different SupF mutation frequen-
cies in a transient DNA replication assay (Hwang et al.,
2002). In this study we further demonstrated that neither
the SupF mutation frequencies nor the spectra of muta-
tions derived from TK or TK cells were significantly
different. Therefore, three different systems demon-
strated that the expression of HSV-1 TK did not increase
mutation frequencies.
The higher mutation frequency (0.5%) observed in
UL3/-gal (TK) (Pyles and Thompson, 1994) could be
influenced by the relative position of the LacZ gene
within the viral genome. The LacZ gene in UL3/-gal is
FIG. 4. Distribution of substituted and deleted bases found in SupF mutants isolated from DNA of KOS/F-A and -B viruses replicated in TK (top)
and TK (bottom) cells. The coding sequence of the SupF gene is shown on the top line from the 5 end of the sequence. , the base deleted at the
nucleotide position shown. Underlined bases indicated substitutions found in the same mutant. The substituted T shown as a pyramid shape at the
bottom refers to the same substitution at nucleotide position 159. Nineteen G to T substitutions were isolated from the same sample, suggesting the
possibility that daughter mutants of this particular mutation could be isolated and led to the bias.
TABLE 4
Classification of SupF Substitutions
Cells
Transitions (%) Transversions (%)
Total
Chi-square
P valueaG:C to A:T A:T to G:C G:C to T:A G:C to C:G A:T to C:G A:T to C:G
TK 24 (43) 0 14 (25) 11 (20) 7 (13) 0 56
TK 36 (37) 2 (2) 38 (39) 19 (20) 2 (2) 0 97 10.13 (0.05)
a The goodness-of-fit was used to examine the p value, based on chi-square value obtained by comparison of the observed and expected numbers
of each type of mutation induced TK or TK cells.
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located near the terminal repeat sequences, whereas
the LacZ gene in tk recombinants (tkLTRZ1 in this study
and tk/-gal in Pyles and Thompson, 1994) is located in
the tk locus, near the OriL sequences. Similarly, the LacZ
gene integrated in the pol locus (HP66 and HPF-11) is
located immediate next to the OriL sequences. Interest-
ingly, the recombinant tk/-gal (Pyles and Thompson,
1994) also exhibited the LacZ mutation frequency of
0.026%, similar to those generated in recombinants
tkLTRZ1, HP66, and HPF-11. Whether there is a position
effect of the target gene on the DNA replication fidelity is
currently under investigation. It is also possible that
different host cells and virus strains used in these stud-
ies could contribute to the differences. Further studies
will be necessary to clarify this possibility.
In conclusion, three different systems demonstrate
that HSV-1 TK does not have mutator activity in replicat-
ing both the LacZ and the SupF genes in infected cells.
Since HSV-1 TK recombinants expressing hTK, hdCK, or
hTMPK exhibited different degrees of ganglionic replica-
tion and reactivation in the animal model (Chen et al.,
1998), it may be of interest to examine DNA replication
fidelity mediated by these recombinants.
MATERIALS AND METHODS
Viruses and cells
Vero cells and its derivatives, V658A, V658B, and
V658C, constructed in this study and Pol A5 cells (Hwang
et al., 1997), were grown and maintained in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with
5% newborn calf serum (NCS) as described previously
(Hwang et al., 1997). Wild-type HSV-1 strain KOS and the
TK-negative recombinants dlsactk (Coen et al., 1989b),
tkLTRZ1 (Davar et al., 1994), and KOS/F-A and -B (Hwang
et al., 2002) were propagated in Vero cells as described
previously (Hwang et al., 2002). These recombinants are
constructed from strain KOS to have modified tk locus.
Recombinant dlsactk contains a deletion of 4 bp at the
SacI site of the tk locus; tkLTRZ1 contains a LacZ gene
inserted at the PstI site and is suitable for -galactosi-
dase (LacZ) mutagenesis assay; KOS/F recombinants
contain an integrated copy of Escherichia coli amplicon
pSupF 1 (Hwang et al., 1997) that contains a SupF gene
for the mutagenesis assay, at the PstI site. HP66 is a
polymerase (pol) null mutant (Marcy et al., 1990) due to
the insertion of the Lac Z gene in the pol locus. Recom-
binant HPF-11 was constructed from HP66 to have the
pSupF1 sequences integrated in the tk locus, assuring
its TK-negative phenotype (data not shown). Both HP66
and HPF-11 were propagated in Pol A5 cells that con-
tained integrated pol gene (Hwang et al., 1997).
Cells with integrated tk gene
To construct cells containing the integrated tk gene,
2  105 Vero cells were cotransfected with the plasmid
pHC658 that contained the tk gene within the 3.6-kb
BamHI fragment of HSV-1 strain KOS DNA, and pSV2-neo
using the transfection reagent Lipofectamine (Invitrogen)
as described previously (Hwang et al., 1997). V658A and
V658B were isolated from two independent transfection
experiments by selecting with 400 g/ml of G418. V658C
cell line was isolated as an independent G418-resistant
clone from the transfection experiment from which
V658B was isolated. Both V658A and V658B, but not
V658C, contained integrated tk sequence and were con-
firmed by Southern blot analyses (Fig. 1).
Plaque autoradiography
The method of plaque autoradiography (Chen et al.,
1998) was modified to examine and quantify the incor-
poration of [3H]thymidine into the plaques formed by TK
and TK viruses. Infected monolayers were incubated at
37°C for 3 days before the addition of [3H]thymidine. The
plates were exposed for 8 days to a tritium plate (Mo-
lecular Dynamics) and then scanned by a phosphorIm-
ager to obtain images and quantitative data. To deter-
mine the relative amount of TK activity, the radioactivity of
10 plaques from each sample was quantified essentially
as described by Chen et al. (1998) and the intensity was
subtracted from the background of KOS/F-B plaques
formed on V658C cells. The relative activity of each
sample was normalized to that of KOS plaques formed
on V658C cells. Plaque size was also measured from the
images of 10 random plaques of each sample to obtain
the average plaque size and normalized to that of KOS
plaques shown on V658C cells.
-Galactosidase mutagenesis assay
A single plaque of each recombinant was plaque pu-
rified and amplified on either Vero or Pol A5 cells to serve
as the viral stock. The titer of this virus was determined
by plaque assay. Approximately 100 PFU of tkLTRZ1 was
inoculated into each of 1  105 V658A, V658B, V658C,
and Vero cells in tissue culture tubes. Similarly, approx-
imately 100 PFU of HP66 or HPF-11 was inoculated into
1  105 PolA5 cells in tissue-culture tubes. After 1 h
absorption, infected cells were washed with serum-free
DMEM and refed with 1.5 ml of DMEM supplemented
with 2% NCS. Seventy-two hours after infection total
infected cells were harvested and treated with three
freeze-thaw cycles. The titers of viral yields were deter-
mined by plaque assay. To measure the relative mutation
frequency of the -galactosidase (LacZ) gene, virus prog-
eny was diluted and directly plated (experiment I) on
Vero cells preseeded on six-well plates at the density of
50 to 150 plaques per well.
Virus samples used for experiment II were indepen-
dently prepared as described above and the titers were
determined. Viral samples were diluted and treated with
Sonifier (VWR) on ice for 30 s, followed by filtration
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through 0.2 m membrane to remove aggregated virus
particles before plating onto Vero cells. This modification
resulted in a 50% decrease in titer. One hour after ab-
sorption, cells were washed with serum free DMEM and
overlaid with 2% methyl cellulose containing DMEM/2%
NCS. Forty-eight to sixty hours after virus inoculations, 1
ml 5-bromo-4-chloro-3-indolyl--D-galactopyranoside (X-
Gal) at a concentration of 750 g/ml was added to each
well for staining plaques expressing -galactosidase.
Twenty-four hours after the addition of X-Gal, blue
plaques began to appear and the intensity of staining
increased continuously afterward. Plaques were exam-
ined between 48 and 72 h after staining by light micro-
scope to identifying clear plaques. Since some clear
plaques might be due to weak expression of -galacto-
sidase and not true LacZ mutations, each clear plaque
identified on this screening process was picked, resus-
pended in 1 ml of DMEM, replated, and examined for its
clear plaque phenotype using X-Gal staining as de-
scribed above. Any clear plaque remained so in the
replating experiment was then confirmed to have a LacZ
mutation. Mutation frequencies were calculated as the
ratio of clear to total plaques examined.
For experiments III and IV, viral samples were briefly
sonicated and plated on Vero cells (experiment III) or Pol
A5 cells (experiment IV) preseeded on 10 cm2 tissue
culture plates at the density of 1200 plaques/plate
(experiment III) or 2200 plaques/plate (experiment IV).
After viral inoculation, the modified method of Pyles and
Thompson (1994) was applied to distinguish clear and
blue plaques. Briefly, 1 h after absorption, infected mono-
layers were washed with serum-free DMEM and overlaid
with 0.75% methyl cellulose containing DMEM/2%NCS.
Twenty-four to thirty-six hours after virus inoculations,
infected cells were washed, fixed, and stained with X-Gal
by using the -galactosidase reporter gene staining kit
(Sigma) according to the manufacturer’s protocol. In-
fected cells were subsequently incubated with anti-gC
antiserum, R47 (kindly provided by G. H. Cohen and
Roselyn J. Eisenberg), at 1:6000 dilution for 30 min at
room temperature. After washing with phosphate-buff-
ered saline (PBS), infected monolayers were incubated
with alkaline phosphatase conjugated anti-rabbit IgG at
1:7500 dilution (Promega) for 30 min at room tempera-
ture. After washing with PBS, fast red reagent (Sigma)
was added to identify the clear plaques as red staining
under microscope, while X-Gal-stained plaques re-
mained blue or dark blue.
SupF mutagenesis assay
The KOS/F recombinants were grown in V658A,
V658B, and V658C cells and the SupF mutagenesis as-
say was performed as described previously (Hwang et
al., 2002). Briefly, less than 200 PFU of KOS/F recombi-
nant virus was inoculated into 1  105 cells. At 72 h
postinfection, infected cells were harvested and total
DNA was extracted and purified. One-fifth of the DNA
was digested with BamHI, ligated with T4 DNA ligase,
purified, and electroporated into E. coliMBM7070. Trans-
formed E. coli was spread onto Luria–Bertani agar plates
containing X-Gal, isopropyl--D-thiogalactopyranoside
(IPTG) and ampicillin. White and light blue colonies that
contained the mutated SupF gene in the pSupF1 replicon
(Hwang et al., 1997) were isolated, and the mutation
frequencies were determined as the ratio of white and
light blue colonies to total colonies recovered (Hwang et
al., 1997). Characterization of mutated SupF genes was
performed as described previously (Hwang et al., 2002).
Southern and Western blots
Total genomic DNA was isolated from 1  107 cells as
described previously (Hwang et al., 1997). Ten micro-
grams of genomic DNA was digested with BamHI restric-
tion enzyme, fractionated on 0.8% agarose, and trans-
ferred to Zeta-Probe GT blotting membrane (Bio-Rad).
Three blots were prepared and each was hybridized with
the probe indicated (Fig. 1A). Probes were labeled with
[-32P]dCTP using the Ready to Go kit (Amersham Phar-
macia Biotech). The 410-bp probe was prepared from the
DNA fragment isolated from PstI- and BamHI-digested
pHC658 DNA. The 850-bp probe was prepared from the
DNA fragment isolated from PstI-digested pHC658 DNA.
The 303-bp probe DNA was PCR amplified from pHC658
using TK11 and TK8 oligonucleotide primers, corre-
sponding to nucleotides 1045–1065 and nucleotides
1348–1327, respectively, of the KOS tk gene (Irmiere et al.,
1989).
For Western blot analysis, 5  105 cells were infected
with viruses at an m.o.i. of 3 or mock-infected; infected
cells were washed with PBS (pH 7.2) and harvested at
7 h postinfection. Infected cell pellets were resuspended
in 30 l of PBS and lysed with the addition of 15 l of 3
Laemmli buffer. Approximately 15 l of each cell lysate
was loaded and fractionated by 10% SDS–PAGE and then
transferred to nitrocellulose membranes. For quantitative
purposes, 5 l of KOS-infected V658C cell lysate was
loaded onto the gel to avoid saturation of signal intensity.
The membrane was incubated with TBST (10 mM Tris–
HCl, pH 8.0; 150 mM NaCl; 0.05% Tween 20) buffer
containing 3% dry milk for 30 min and probed with rabbit
anti-TK antiserum (at 1:2000 dilution) (W. W. Summers;
Yale University) for 1 h followed by the incubation with
alkaline phosphatase conjugated goat anti-rabbit anti-
serum (at 1:7500 dilution) (Promega) for 1 h. The blot was
incubated with Lumi-Phos WB solution (Pierce) for 3 min
and then exposed to X-ray film for 1 min. The intensity of
band corresponding to TK polypeptides was measured
by densitometry using the Gel Doc 2000 apparatus and
Quantity One software (Bio-Rad). The relative amount of
395HSV-1 TK LACKS MUTATOR ACTIVITY
TK in each sample was normalized to the amount of TK
in KOS-infected cell lysate, defined as 100%.
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